No TAAR5 expression imbalance was found in the datasets which include cortical specimens from the patients with bipolar disorder (GSE5388, GSE5389, GSE53239, GSE80655), schizophrenia (GSE17612, GSE80655), Alzheimer’s disease (GSE53697), Huntington’s disease (GSE79666, GSE64810), Parkinson’s disease (GSE20295, GSE68719), multiple sclerosis (GSE123496), or frontotemporal lobar degeneration (GSE13162). This evidence concerns the gene TAAR5 and early-onset autosomal dominant Alzheimer disease.